News

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

Union-Jack-flag-with-Brexit-word

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Read More

Finalist in Tolley’s Taxation Awards 2018 – Confluence Tax

Tolleys-Taxation-Awards-2018-Finalist-logo

  CONFLUENCE Tax is delighted to announce the team has been shortlisted in the Tolley’s Taxation Awards 2018. The team is a finalist in the category Best Independent Consultancy Firm and is the smallest company to be selected. ‘It’s fantastic to be chosen as a finalist, especially as it’s the first time we’ve applied for an award.…

Read More

HMRC Enterprise Centre: why the delays?

Two roads and a sign saying now one way and later the other

IN LIGHT of the November 2017 budget where the Chancellor announced the importance of supporting the R&D sector and growth of small businesses, why are we experiencing delays at the HMRC Enterprise Centre? Confluence Tax’s Anne-Marie Rickels looks at the problems and what can be done. Venture Capital Schemes, such as VCT, EIS and SEIS,…

Read More

BUDGET 2017: BEST BITS

Child-using-technology

CONFLUENCE TAX held a post-budget tax briefing for those in the biotech and tech space on November 23, 2017. Here we’ve shared the ‘need to knows’ for all knowledge-intensive companies and investors WHILE MANY commentators on the autumn budget were unmoved, we welcomed various tax changes that affect the knowledge-based businesses we work with –…

Read More

Budget 2017 tax predictions: EIS, SEIS and VCT relief

Compass-on-paper-with-background-VCT-accounts

SWEEPING aside the Chancellor’s big challenges of income tax rates, self-employed vs employed workers and the headache of the gig economy, an area of tax with direct relevance to technology and biotechnology companies that I believe is ripe for change in the 2017 budget is venture capital schemes – EIS, SEIS and VCT relief. These…

Read More